Clinical Trial Update: A Prospective Study on 18F-DCFPyL PET/CT Imaging in Biochemical Recurrence of Prostate Cancer [Phase 3]

View source ↗

Summary

Prospective Phase 3 trial evaluating 18F-DCFPyL PET/CT imaging in biochemical recurrence of prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 18F-DCFPyL (DCFPyL radiotracer for PSMA imaging)

Snippet

Sponsor: Curium PET France | Conditions: Prostate Cancer Recurrent | Phase 3 | Status: UNKNOWN